IMI Site Wed, 22 Sep 2021 18:54:10 +0000 en-US hourly 1 IMI Site 32 32 Dechra acquires exclusive license from Hassinger Biomedical for Equine ProVet APC ™ – The Horse Wed, 22 Sep 2021 18:17:52 +0000

Dechra Veterinary Products is pleased to announce the acquisition of the veterinary marketing and distribution rights for the ProVet APC ™ (Autologous Platelet Concentrate) and ProVet BMC ™ (Bone Marrow Concentrate) systems from Hassinger Biomedical. These two patented medical devices concentrate platelets or bone marrow in 90 seconds with a treatment time of 2.5 minutes from start to finish.

The ProVet APC System is a revolutionary device and is arguably the fastest and most transportable platelet concentrator available for the veterinary industry with a total weight of less than 3 pounds. Some of the features of the system include the ability to isolate approximately 90% of the platelets and growth factors available, providing the highest level of reproducibility with a low coefficient of variance of 3.5% and a 97% reduction in the number of Red cells.

ProVet APC’s proprietary technology consistently delivers 6-8ml of a 7.8-fold high concentration of platelet rich plasma and healing concentrate derived from 54ml of whole blood into the 60ml system.

Mike Eldred, President of Dechra North America, said: “The medical industry has long recognized that harnessing the growth factors present in platelets positively improves healing outcomes and reduces recovery time from soft tissue damage. . These two products will be great additions to our equine product line and will further strengthen our position in the regenerative veterinary medicine market ”.

“ProVet APC has become the most sought-after regeneration system for equine athletes,” said Amy Hassinger, CEO of Hassinger Biomedical. “We believe Dechra is uniquely positioned, with its experience in the veterinary industry, to meet the growing global demand from veterinarians and their customers for the ProVet APC and BMC Regenerative Therapy Systems. “

This addition of Provet APC products to Dechra’s equine portfolio will complement our industry-leading Orthokine® Vet irap joint therapy and provide veterinarians with a single partner for their regenerative medicine needs.

About Dechra

Dechra Veterinary Products, located in Overland Park, Kansas, is the US sales and marketing division of Dechra Pharmaceuticals PLC, a UK listed company dedicated to the animal health market. Dechra’s equine product line includes Osphos® (injection of clodronate), Orthokine® vet irap 10 and 60, Osteokine® (PRP), Equidon® (domperidone) Gel, the Vetivex® range of parenteral fluids, Phycox® EQ and a full line of topical dermatological products. The recent addition of Zimeta® (dipyrone injection) further expands Dechra’s equine offering. Dechra Veterinary Products’ companion animal portfolio focuses on endocrinology, dermatology, ophthalmology, anesthesia, fluid therapy, pain management, joint health support and dental care. Our pet brands include Vetoryl® Capsules (trilostane), Zycortal® Suspension (suspension for injection of deoxycorticosterone pivalate), Osurnia® (florfenicol-terbinafine-betamethasone acetate), Mirataz® (mirtazapine transdermal ointment), and Phycox® joint health supplements, Porus® One as well as a complete topical dermatological line for veterinary use. For more information, please visit or call (866) 933-2472.

Source link

]]> 0
Activist investor Bluebell takes stake in GSK Wed, 22 Sep 2021 17:03:00 +0000 A GlaxoSmithKline factory is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan / Pool via REUTERS / File Photo

Sept. 22 (Reuters) – Activist investor Bluebell Capital Partners has taken an estimated € 10million stake in UK pharmaceutical group GlaxoSmithKline (GSK.L) in a bid to shake up management, a report from the Financial Times.

Bluebell said in a letter to GSK chairman Jonathan Symonds that chief executive Emma Walmsley would have to reapply for her post because she would have “renewed her credibility both internally and externally,” according to the FT report.

Earlier this year, activist Elliott also took a stake in GSK, calling for a change in leadership at the company. Bluebell largely supported Elliott’s demands, the FT said. Read more

GSK confirmed that Bluebell made requests in a letter.

“We continue to engage extensively with our shareholders with more than 500 meetings so far this year,” GSK said in a statement.

“They expressed widespread and strong support for our plans to bring about a radical change in terms of growth and performance, and made it clear that they need to focus on execution,” the company added.

The British pharmaceutical major, with a market value of more than 71 billion pounds ($ 96.95 billion), in July rejected Elliott’s demands to change its board of directors and sell its consumer health arm. Read more

GSK has plans to turn its consumer healthcare arm into a separately listed company, a move that will generate an £ 8 billion windfall and other financial benefits to spur drug development in its sub-pharmaceutical business. efficient. Read more

Bluebell was part of a successful investor campaign to oust Danone (DANO.PA) Chairman and CEO Emmanuel Faber in March. Read more

($ 1 = 0.7323 pounds)

Report by Aditi Sebastian in Bengaluru and Ludwig Burger in Frankfurt. Editing by Jane Merriman

Our Standards: Thomson Reuters Trust Principles.

]]> 0
Ceramic sanitary ware market size, growth and key players – Geberit Group, Villeroy & Boch AG, Lixil Group Corporation, Rak Ceramics, Toto Ltd., Kohler Co., Duravit AG Wed, 22 Sep 2021 15:12:54 +0000

New Jersey, United States, – The Ceramic Sanitary Ware Market The research report is an in-depth study that provides industry-wide insights into existing and emerging growth patterns, end-user analysis, and other key data that has been tested and validated by experts. and industry professionals. The report studies the market for importance, share, size, demand and supply, models, competitive landscape, industry chain analysis, and other significant factors. The report also provides a detailed overview of the driving forces of the industry, along with the micro and macroeconomic factors that are likely to affect its development.

The Ceramic Sanitary Ware market research report assesses the global ceramic sanitary ware industry market and includes sales and capacity forecast for the anticipated period 2021-2028. The factors driving the growth of the industry are highlighted in the report. The report divides the sanitary ceramics market into broad categories such as shapes, applications, end user, technology, and others for better understanding. These segments are carefully examined to provide a more detailed perspective on the global and regional markets. The report also examines key industry players including their product portfolios, company overviews, strategic growth strategies, revenue generation, market share and size, geographic presence and size. of the market. development and manufacturing capabilities.

The ceramic sanitary ware market was valued at USD 29.21 billion in 2019 and is expected to reach USD 48.76 billion by 2027, with a CAGR of 6.6% from 2020 to 2027.

The report has conducted extensive research on the market segments and sub-segments and clarified which market segment will dominate the market during the forecast period. To help clients to make informed decisions about business investment plans and strategies in the Ceramic Sanitary Products market, the report involves in-depth information regarding regional market performance and competitive analysis.

The report covers an in-depth analysis of the major market players in the market, along with their business overview, expansion plans, and strategies. The major players studied in the report include:

Geberit Group, Lixil Group Corporation, Villeroy & Boch AG, Rak Ceramics, Toto Ltd., Kohler Co., Duravit AG, HSIL, Duratex Sa, Roca Sanitario SA

Segmentation of the ceramic sanitary ware market

Ceramic Sanitary Ware Market by Type

• Washbasins / WC
• Washbasins

Ceramic Sanitary Ware Market by Application

• Commercial
• Residential

Ceramic Sanitary Ware Market by Technology

• Slip casting
• Die casting
• Band casting
• Isostatic casting

Scope of Ceramic Sanitary Ware Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2020
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2028
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of the report (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of personalized shopping options to meet your exact research needs. Explore purchasing options

Geographic segment covered in the report:

The Ceramic Sanitary Ware report provides information about the market area, which is itself further subdivided into sub-regions and countries / regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region during the estimated period.

  • The Middle East and Africa (GCC countries and Egypt)
  • North America (United States, Mexico and Canada)
  • South America (Brazil etc …)
  • Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
  • Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Key questions answered in the report:

  • Who are the main global players in this sanitary ceramics market?
  • What is their company profile, their product information, their contact details?
  • What was the global market status of the market?
  • What was the capacity, production value, cost and profit of the market?
  • What are the projections of the global industry taking into account the capacity, output and production value?
  • What will the cost and profit estimate be?
  • What will be the market share, supply and consumption?
  • What is the market chain analysis by upstream commodity and downstream industry?
  • What are the market dynamics of the market?
  • What are the challenges and opportunities?
  • What should be the entry strategies, the countermeasures to the economic impact, the marketing channels for the industry?

Visualize Ceramic Sanitary Ware Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform for narrative storytelling for this market. VMI offers in-depth forecasting trends and accurate insights into over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a holistic overview and global competitive landscape with regard to region, country and segment as well as the major players in your market. Present your market report and findings with a built-in presentation function, saving over 70% of your time and resources for investor arguments, sales and marketing, R&D and product development. VMI enables data delivery in interactive Excel and PDF formats with over 15+ key market indicators for your market.

About Us: Verified Market Research®

Verified Market Research® is a leading global research and consulting company providing advanced analytical research solutions, personalized advice and in-depth data analysis for over 10 years to individuals and businesses seeking precise research, reliable and up to date. technical data and advice. We provide insight into strategic and growth analysis, the data needed to achieve business goals and help make critical revenue decisions.

Our research studies help our clients make better data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable information. The industries we cover cover a broad spectrum including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and gas. Etc.

At Verified Market Research, we help understand the holistic factors indicating the market and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise, and years of collective experience to produce informative and accurate research.

After serving over 5,000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s largest consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for personalized research and consulting projects for businesses around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

United States: +1 (650) -781-480
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768



Source link

]]> 0
TILT: Receives approval to begin medical use of marijuana operations for its Brockton, Massachusetts dispensary. Wed, 22 Sep 2021 13:28:09 +0000

PHOENIXTILT Holdings Inc. (“TILT or the” Company “) (NEO: TILT) (OTCQX: TLLTF), a global provider of commercial cannabis solutions that include inhalation technologies, cultivation, manufacturing, processing, drug development brand and retail, announced that the Massachusetts Cannabis Control Board (“CCC”) approved the subsidiary of TILT, Commonwealth Alternative Care, Inc. (“CAC”), to begin its retail activities at its next Brockton dispensary, efficient September 21, 2021, for the medical use of marijuana.

CAC Brockton dispensary is located 1090 West, Chestnut Street, and the opening hours will be 10 a.m. to 6 p.m., from Monday to Sunday. CAC Brockton has also been granted an Interim Retail Establishment License and anticipates that adult operations will be fully approved and officially begin following the final inspection by the CCC.

The CAC Brockton will open its doors to patients on October 1st as part of a “soft opening” to allow visits by local officials as well as hands-on budget training and operational readiness. At saturday 16 october, CAC Brockton will celebrate its grand opening with a weekend of festivities that includes a groundbreaking ceremony and experiential cannabis brand activations.

“We are delighted to finally open our second dispensary in the state,” said Gary Santo, CEO of TILT. “It has been a long journey for our Massachusetts team, and with final inspections for adult use underway at both of us Brockton and Taunton locations, we look forward to adding adult retail to both before the end of the year.

About TILT

TILT helps cannabis companies build brands. Through a portfolio of companies providing technology, equipment, cultivation and production, TILT provides services to cannabis brands and retailers in 36 states of the we, as good as Canada, Israel, Mexico, South America and the European Union. The main activities of TILT include Jupiter Research LLC, a wholly owned subsidiary and leader in the vaporization segment focused on the design, research, development and manufacture of computer hardware; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in new York. TILT is headquartered at Phoenix, Arizona. For more information, visit

Forward-looking information

This press release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans for the future, and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may include, without limitation, the expected timing of the approval of adult use transactions at CAC Brockton and Taunton, the planned timeline for the smooth opening and official opening of CAC, direction, outlook, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook for TILT, and includes statements on, among other things, future developments, operations, expansions and strategy of TILT. In general, forward-looking information can be identified by the use of forward-looking terms such as “plans”, “expects” or “does not expect”, “is planned”, “budget”, “planned”, ‘Estimates’,’ forecasts’, ‘considers’,’ anticipates’ or ‘does not anticipate’, or ‘believes’, or variations of these words and expressions or state that certain actions, events or results’ might’, ‘ could ‘,’ would ‘,’ could ‘or’ will be taken ‘,’ occur ‘or’ be reached ‘. These statements should not be interpreted as guarantees of future performance or results. These statements are based on certain important factors, assumptions and analyzes that have been applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, TILT’s ability to expand its operations and expected future developments, as well as other factors considered reasonable under the circumstances.

While these statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that they will be made under the conditions described above and that such forward-looking information will prove to be accurate, as the results actual and future events could differ materially from those anticipated in this forward-looking information. Therefore, readers should not place undue reliance on forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances, except as required by applicable law.

By their nature, forward-looking information is subject to risks and uncertainties, and there are a variety of important factors, many of which are beyond TILT’s control, and which may cause actual results to differ materially from those discussed in forward-looking information. staring statements.

For more information regarding forward-looking statements and their associated risks, please refer to the “Risk Factors and Uncertainties” section of the Company’s Annual Information Form for the year ended. December 31, 2020, which is available on the Company’s SEDAR profile at



Sean Mansouri


Raise IR



Juliette Fairbrother

MATTIO Communication


T: 631.338.5343

Source link

]]> 0
FDA Approves Incyte Eczema Cream with Boxed Warnings Wed, 22 Sep 2021 01:47:00 +0000 Signage can be seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, USA on August 29, 2020. REUTERS / Andrew Kelly

Sept. 21 (Reuters) – The U.S. Food and Drug Administration on Tuesday approved Opzelura Cream from Incyte Corp (INCY.O) for the treatment of inflammatory atopic dermatitis, commonly known as eczema, in adolescents and adults with boxed warnings.

Opzelura’s label carries the health regulator’s JAK class warning, signaling the risks of serious infections, increased risk of heart attack, stroke, or cardiac death.

Shares of the company, which plans to make the cream available at U.S. drug stores in the coming weeks, fell about 5% to $ 72.26 after the bell.

RBC analyst Brian Abraham said in a note to a client that boxed warnings may have limited impact on long-term opportunities and short-term stock reaction.

The brokerage’s physician survey had indicated that a boxed warning on Opzelura’s label could reduce adoption by about 30%, especially in lighter patients, Abraham said in a note. customer.

Ruxolitinib cream is the first topical inhibitor of JAK, a class of treatments that work by blocking inflammatory enzymes Janus kinases, to be approved in the United States.

Recent safety concerns regarding oral JAK inhibitors such as the arthritis drug from Pfizer Inc (PFE.N) Xeljanz and the treatment Rinvoq from AbbVie Inc (ABBV.N) and Eli Lilly (LLY.N) Olumiant , have resulted in regulatory delays. Read more

Atopic dermatitis is a chronic skin condition that causes inflammation and irritation of the skin. It affects about 30% of the American population, mostly children and adolescents, according to the National Institute of Allergy and Infectious Diseases.

Ruxolitinib is approved as an oral tablet under the brand name Jakafi in the United States for the treatment of a type of blood cancer called polycythemia essential, rare myelofibrosis in bone marrow cancer, and acute graft-versus-bone disease. host.

Brian of RBC estimates US sales at over $ 550 million for the year for the atopic dermatitis indication.

Reporting by Bhanvi Satija and Manojna Maddipatla; Editing by Aditya Soni and Vinay Dwivedi

Our Standards: Thomson Reuters Trust Principles.

]]> 0
Improve Your Pet’s Care: Why Pet Owners Choose Specialty Veterinary Medicine Tue, 21 Sep 2021 23:39:34 +0000

(GTU) – As individuals, we consult with our family physicians for routine wellness checks and general health concerns. But sometimes when our primary care doctor is not sure or feeling confident about diagnosing a problem, they will refer you to a specialist for further examination. You wouldn’t guess. But like us, our pets also have specialist doctors!

MedVet is a family of emergency and specialty veterinary hospitals committed to providing exceptional care for your pets. Board certified specialists and highly trained emergency vets work closely with you and your family vet to provide the best possible care for your dog or cat.

If you want a more personal approach to veterinary care, Medvet is for you. They recognize that our pets are an important part of the family. The staff strive to provide the most advanced medical care with the utmost compassion for you and your pet. Their goal is to work with you and your family veterinarian to provide the specialist care needed to get your pet home as quickly as possible.

The clinic is relatively new to the Salt Lake City area. MedVet opened to improve the lives of pets, their loving families and the veterinary community in the Salt Lake City area and the wider communities of Weber, Davis, Morgan and Summit counties in August 2020.

It’s the only place to go if your pet requires special care. Their team of experienced and compassionate clinicians work with your family veterinarian to provide advanced medical care for your pet. The specialized services available include intensive care, dentistry and oral surgery, dermatology, internal medicine, medical oncology, radiology and surgery.

Do you think your pet needs specialist veterinary care? Get more information on or speak with your family veterinarian about a referral to one of their board certified specialists. You can also call the hospital directly to speak with a member of the care and service team.

MedVet offers a full range of services for your animals:

  • Surgery
  • Radiology
  • Medical oncology
  • Internal Medicine
  • Emergency medicine
  • Dermatology
  • Critical care
  • Cardiology

More Lastest on GTU

This story contains sponsored content.

Source link

]]> 0
Evacuation recommendation lifted for part of Flat Rock Tue, 21 Sep 2021 21:57:35 +0000

A group of voluntarily evacuated residents of Flat Rock have been cleared by Wayne County and State health officials to return home – while another part of town is still affected by noxious fumes in the sanitary sewer system from a fuel spill at the nearby Ford assembly plant. awaits a word on when residents can safely return.

Mayor Mark Hammond, in a letter to residents posted to the city’s Facebook page on Tuesday, said the Michigan Department of Health and Human Services and the Wayne County Department of Public Health released Monday night information on the analysis of houses and sewers in “Zone 2,” an area of ​​the city bounded by Gibraltar Road to the north, Huron River Drive to the south and west, and Tamarack Drive to the south and east.

“Based on these results, any gasoline vapor remaining in the Zone 2 sewers from the gasoline release reported on September 1 is not expected to harm human health, as contamination levels in the sanitary sewers are below levels that could lead to an indoor hazard, ”Hammond said.

But the wait continues for residents of “Zone 1”, a part of over 3 square miles of the city between Gibraltar, Cahill and Woodruff roads and I-75, where benzene and other chemicals have been released. been detected in sewers and in homes with high, flammable levels around Labor Day weekend.